by Shana Cristoferi | Jun 26, 2019 | Appili Therapeutics, NeuroQuest, News
See full Entrevestor article here Shares of Halifax drug discovery company Appili Therapeutics Inc. begin trading on the TSX Venture exchange today. The company, whose long-term goal is to produce drugs that can combat antibiotic-resistant viruses, issued...
by administrator | Nov 2, 2017 | Appili Therapeutics, News
For Immediate Release HALIFAX, Nova Scotia – October 30, 2017 – Appili Therapeutics Inc. (the “Company” or “Appili”), an anti-infective drug development company, announced today that both the US Food and Drug Administration (FDA) and Health Canada have cleared its IND...